TEVA

Teva Pharmaceutical Industries Limited
D

TEVA

22.090
USD
0.78
(3.64%)
Market Closed
Volume
577,791
EPS
2
Div Yield
-
P/E
-26
Market Cap
25,029,079,227
Related Instruments
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    GSK
    GSK
    0.155
    (0.46%)
    33.595 USD
    LLY
    LLY
    11.01
    (1.45%)
    768.44 USD
    M
    MNK
    -0.06490
    (-16.07%)
    0.33900 USD
    MRK
    MRK
    -1.390
    (-1.40%)
    98.150 USD
    NVS
    NVS
    0.340
    (0.35%)
    97.070 USD
    PFE
    PFE
    0.595
    (2.31%)
    26.360 USD
    P
    PRGO
    0.060
    (0.23%)
    25.770 USD
    More
News

Title: Teva Pharmaceutical Industries Limited

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.